APOE and Alzheimer disease: In this study, we propose a novel approach for the early detection of AD with other groups and to differentiate the most similar clinical entities of MCIs and MCIc by combining biomarkers from two imaging modalities (sMRI, FDG-PET) with CSF (biochemical protein level) and APOE genotype biomarkers obtained from each patient.